RT-3 Rt-3 is an investigational peptide that has gained major attention for its potential benefits in weight management, metabolic optimization, and appetite regulation. It is commonly researched for its ability to support significant fat loss, improve insulin sensitivity, and enhance overall metabolic function. Rt-3 works through a unique triple-agonist mechanism by targeting GLP, GIP, and glucagon receptors simultaneously, which may help regulate hunger signals, increase energy expenditure, and improve the body’s ability to utilize glucose and stored fat more efficiently. Potential benefits reported in clinical research include reduced appetite, improved body composition, decreased visceral fat, enhanced metabolic health, and support for blood sugar regulation. Many individuals are also interested in its potential effects on cardiovascular markers and long-term metabolic wellness. While generally well tolerated in research settings, possible side effects may include nausea, reduced appetite, digestive discomfort, fatigue, or mild irritation at the injection site, particularly during dose adjustments.